Should benign enlargement of subarachnoid spaces be followed radiologically?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benign Enlargement of Subarachnoid Spaces: Radiological Follow-up

Routine radiological follow-up is not necessary for benign enlargement of subarachnoid spaces (BESS) in asymptomatic infants, as this is a self-limiting condition that resolves spontaneously by 18-24 months of age.

Initial Assessment and Diagnosis

When BESS is identified on imaging, the key diagnostic features include:

  • Enlarged frontal subarachnoid spaces (>3 mm sinocortical width, >4 mm craniocortical width, or >6 mm interhemispheric width) with normal or minimally enlarged ventricles 1
  • Normal neurodevelopmental status is the critical distinguishing feature from pathological conditions 1, 2
  • Macrocephaly is common, with head circumference often at or above the 95th percentile, but growth should parallel normal curves 1, 3

The distinction from brain atrophy is crucial: BESS shows normal or minimally enlarged ventricles, whereas brain atrophy presents with both passive subarachnoid space dilatation AND ventriculomegaly 1.

Recommended Follow-up Strategy

For Confirmed BESS (Asymptomatic):

  • One follow-up MRI at 12-18 months to demonstrate stability and resolution is reasonable but not mandatory 4, 2
  • Clinical follow-up without mandatory imaging is the preferred approach for asymptomatic cases 4
  • No long-term imaging surveillance is necessary once the benign nature is confirmed 4
  • Head circumference monitoring should continue with measurements plotted on growth charts for 6 months after diagnosis 1

When to Consider Repeat Imaging:

Repeat imaging should only be performed if:

  • Clinical deterioration occurs (new neurological symptoms, developmental regression) 4
  • Abnormal head growth velocity deviates from the normal curve 1
  • New symptoms suggesting complications develop 4

Natural History and Prognosis

  • Resolution occurs spontaneously by 18-24 months of age in the vast majority of cases 2, 3
  • >80% of cases remain stable in size over time 4
  • Normal neurodevelopment is expected when no associated brain anomalies are present 1, 2
  • Head circumference typically remains at or above the 95th percentile even after subarachnoid space normalization 3

Important Clinical Pitfalls

Avoid Misdiagnosis:

  • Do not confuse BESS with subdural collections: BESS is associated with incidental subdural collections in approximately 5.8% of cases, which are not indicative of abusive head injury when occurring in the context of BESS 5
  • Do not diagnose brain atrophy: This requires both enlarged subarachnoid spaces AND ventriculomegaly, carrying a poor neurodevelopmental prognosis unlike BESS 1
  • Do not pursue unnecessary neuroimaging: Further imaging procedures are not needed once BESS is confirmed with normal neurodevelopment 1

Family Counseling:

  • Reassure families about the benign, self-limiting nature of this condition 4, 3
  • Document family history of macrocephaly, which is commonly present 3
  • Emphasize normal development expectations when no associated anomalies exist 1, 2

References

Research

Benign enlargement of sub-arachnoid spaces in infancy.

Journal of pediatric neurosciences, 2014

Research

Benign subarachnoid space enlargement of infancy.

Journal of the National Medical Association, 2001

Guideline

Management of Perineural Cyst on Thoracic Spine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.